Episode 114: How AI, Supply Chains, and Smart Strategy are Redefining Biotech Investment and Venture Capital
How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of science and technology. A Tulane alumnus and “supply chain junkie,” Cain shares how curiosity, data-driven insight, and strategic storytelling can set biotech innovators apart.
In this episode, you’ll learn:
- The biggest mistakes biotech startups make—and how to avoid them.
- Why understanding incentives, storytelling, and systems is key to scaling innovation.
- How AI, data ownership, and new consumer health models are reshaping the future of biotech.
Tune in to discover how KdT Ventures is rethinking biotech investment—and what it takes to turn scientific insight into lasting impact.
Links:
Connect with Cain McClary, MD, and check out KdT Ventures.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about PathAI.
Check out our fireside chat with Walter Isaacson.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
